Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 77 of 79

  1. Methylation of HIN-1 is associated with poor outcomes in patients with ovarian clear cell carcinoma (OCCC), which is regarded to be an aggressive, chemo-resistant histological subtype. This study aimed to eval...

    Authors: Chih-Ming Ho, Chi-Jung Huang, Shih-Hung Huang, Shwu-Fen Chang and Wen-Fang Cheng
    Citation: BMC Cancer 2015 15:789
    Content type: Research article Published on:

  2. The identification of pathologically altered neutrophil granulocyte migration patterns bears strong potential for surveillance and prognostic scoring of diseases. We recently identified a strong correlation be...

    Authors: Lea Bornemann, Marc Schuster, Saskia Schmitz, Charlyn Sobczak, Clara Bessen, Simon F. Merz, Karl-Heinz Jöckel, Thomas Haverkamp, Matthias Gunzer and Joachim R. Göthert
    Citation: BMC Cancer 2020 20:650
    Content type: Research article Published on:

  3. Rhabdomyosarcoma (RMS) is a malignant soft tissue sarcoma of childhood including two major histological subtypes, alveolar (ARMS) and embryonal (ERMS) RMS. Like other human malignancies RMS possesses high meta...

    Authors: Valentina Masola, Claudio Maran, Evelyne Tassone, Angelica Zin, Angelo Rosolen and Maurizio Onisto
    Citation: BMC Cancer 2009 9:304
    Content type: Research article Published on:

  4. Liver resection had been regarded as a standard treatment for primary hepatocellular carcinoma (HCC). However, early mortality and recurrence after surgery were still of major concern. RAM (Risk Assessment for...

    Authors: Heng-Yuan Hsu, Ming-Chin Yu, Chao-Wei Lee, Hsin-I Tsai, Chang-Mu Sung, Chun-Wei Chen, Shu-Wei Huang, Cheng-Yu Lin, Wen-Juei Jeng, Wei-Chen Lee and Miin-Fu Chen
    Citation: BMC Cancer 2017 17:742
    Content type: Research article Published on:

  5. Abundant evidence has manifested that long noncoding RNAs (lncRNAs) are closely implicated in human cancers, including hepatocellular carcinoma (HCC). Remarkably, lncRNA FAM83H antisense RNA 1 (FAM83H-AS1) has...

    Authors: Wenpeng Zhao, Jiang Guo, Honglu Li, Liang Cai, Youjia Duan, Xiaopu Hou, Zhenying Diao, Xihong Shao, Hongliu Du and Changqing Li
    Citation: BMC Cancer 2021 21:1310
    Content type: Research article Published on:

  6. Statins have long been used as anti-hypercholesterolemia drugs, but numerous lines of evidence suggest that they may also bear anti-tumour potential. We have recently demonstrated that it was possible to isola...

    Authors: Julie Follet, Lionel Rémy, Vincent Hesry, Brigitte Simon, Danièle Gillet, Pierrick Auvray, Laurent Corcos and Catherine Le Jossic-Corcos
    Citation: BMC Cancer 2011 11:491
    Content type: Research article Published on:

  7. No standard of care is established for plasmablastic lymphoma (PBL) and prognosis remains extremely poor, given that patients relapse early after chemotherapy and display resistance to commonly applied cytosta...

    Authors: Alessandro Broccoli, Laura Nanni, Vittorio Stefoni, Claudio Agostinelli, Lisa Argnani, Michele Cavo and Pier Luigi Zinzani
    Citation: BMC Cancer 2018 18:645
    Content type: Case report Published on:

  8. Radiotherapy (RT) following breast-conserving surgery (BCS) is mainly used to decrease the rate of ipsilateral breast tumor recurrence (IBTR) in women with breast ductal carcinoma in situ (DCIS). Recent studie...

    Authors: Sung-Hsin Kuo, Ling-Ming Tseng, Shou-Tung Chen, Yasuaki Sagara, Yuan-Ching Chang, Hsien-Tang Yeh, Yao-Lung Kuo, Chih-Chiang Hung, Tzu-Pin Lu, Yi-Hsuan Lee, Masakazu Toi and Chiun-Sheng Huang
    Citation: BMC Cancer 2023 23:865
    Content type: Study Protocol Published on:

  9. Glioblastomas (GBM) are typically comprised of morphologically diverse cells. Despite current advances in therapy, including surgical resection followed by radiation and chemotherapy, the prognosis for patient...

    Authors: Silvia Valensin, Chiara Ghiron, Claudia Lamanna, Andreas Kremer, Marco Rossi, Pietro Ferruzzi, Marco Nievo and Annette Bakker
    Citation: BMC Cancer 2009 9:196
    Content type: Research article Published on:

  10. Long non-coding RNA (LncRNA) HOTAIR was amplified and overexpressed in many human carcinomas, which could serve as a useful target for cancer early detection and treatment. The 99mTc radiolabeled antisense oligon...

    Authors: Jiongyu Ren, Xiyuan Zhang, Jiang Cao, Jiali Tian, Jin Luo, Yaping Yu, Fengkui Wang and Qian Zhao
    Citation: BMC Cancer 2022 22:79
    Content type: Research Published on:

  11. There is paucity of data regarding outcomes of children, adolescents and young adults (CAYA) patients with non-Hodgkin lymphoma (NHL) undergoing autologous stem cell transplantation (ASCT).

    Authors: Oren Pasvolsky, Roland L. Bassett, Sassine Ghanem, Branko Cuglievan, Priti Tewari, Chitra Hosing, Samer Srour, Jeremy Ramdial, Kris M. Mahadeo, Sajad Khazal, Demetrios Petropoulos, Uday Popat, Muzaffar Qazilbash, Partow Kebriaei, Richard Champlin, Elizabeth J. Shpall…
    Citation: BMC Cancer 2023 23:1258
    Content type: Research Published on:

  12. Overall survival is the true endpoint for most randomized controlled trials (RCTs) of malignant tumors, whereas progression-free survival (PFS) is considered the most reliable surrogate endpoint for overall su...

    Authors: Kazuhiro Tanaka, Masanori Kawano, Tatsuya Iwasaki, Ichiro Itonaga and Hiroshi Tsumura
    Citation: BMC Cancer 2019 19:56
    Content type: Research article Published on:

  13. Multiple myeloma is a cancer in the bone marrow causing bone destruction. Patients experience various symptoms related to the disease and/or treatment, such as pain and fatigue, leading to poorer quality of li...

    Authors: Rikke Faebo Larsen, Mary Jarden, Lisbeth Rosenbek Minet, Ulf Christian Frølund, Sören Möller and Niels Abildgaard
    Citation: BMC Cancer 2020 20:169
    Content type: Research article Published on:

  14. In neuro-oncology, the inclusion of tumor patients in the molecular tumor board has only become increasingly widespread in recent years, but so far there are no standards for indication, procedure, evaluation,...

    Authors: Lisa S. Hönikl, Sebastian Lange, Vicki M. Butenschoen, Claire Delbridge, Bernhard Meyer, Stephanie E. Combs, Anna Lena Illert and Friederike Schmidt-Graf
    Citation: BMC Cancer 2024 24:108
    Content type: Research Published on:

  15. Hypoxic microenvironments in tumors contribute to transformation, which may alter metabolism, growth, and therapeutic responsiveness. The α-enolase gene encodes both a glycolytic enzyme (α-enolase) and a DNA-b...

    Authors: Kara C Sedoris, Shelia D Thomas and Donald M Miller
    Citation: BMC Cancer 2010 10:157
    Content type: Research article Published on:

  16. Bilateral diffuse uveal melanocytic proliferation (BDUMP) is a paraneoplastic ocular syndrome occurring in patients with systemic, often occult but advanced carcinoma and is the hallmark of poor prognosis. Ocu...

    Authors: Maria Pefkianaki, Rupesh Agrawal, Parul Desai, Carlos Pavesio and Mandeep S Sagoo
    Citation: BMC Cancer 2015 15:23
    Content type: Case report Published on:

  17. Liver cirrhosis is a well-known risk factor for hepatocellular carcinoma (HCC). However, some HCC cases can also originate from non-cirrhotic livers. The aim of this study was to identify key circular RNAs (ci...

    Authors: Hongyu Li, Liangliang Xu, Pengsheng Yi, Lian Li, Tao Yan, Liang Xie and Zhijun Zhu
    Citation: BMC Cancer 2022 22:857
    Content type: Research Published on:

  18. Oxaliplatin is a platinum derivative that has shown efficacy in advanced hepatocellular carcinoma. S-1 is an oral fluoropyrimidine that has substituted for 5-fluorouracil in many cancers. This was a multicente...

    Authors: Dae-Won Lee, Kyung-Hun Lee, Hee-Jun Kim, Tae-Yong Kim, Jin-Soo Kim, Sae-Won Han, Do-Youn Oh, Jee Hyun Kim, Seock-Ah Im and Tae-You Kim
    Citation: BMC Cancer 2018 18:252
    Content type: Research article Published on:

  19. Malignant pleural mesothelioma is a rare disease known to be resistant to conventional therapies. A better understanding of mesothelioma biology may provide the rationale for new therapeutic strategies. In thi...

    Authors: Alice Melotti, Antonio Daga, Daniela Marubbi, Annalisa Zunino, Luciano Mutti and Giorgio Corte
    Citation: BMC Cancer 2010 10:54
    Content type: Research article Published on:

  20. Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a heterogenous group of tumors. Findings from the phase III NETTER-1 trial showed that treatment of unresectable/metastatic progressive gastroi...

    Authors: J. Smith-Palmer, O. R. Leeuwenkamp, J. Virk and N. Reed
    Citation: BMC Cancer 2021 21:10
    Content type: Research article Published on:

  21. Globally, the burden of endometrial endometrioid carcinoma (EEC) increases annually. However, the histological grade of EEC remains unelucidated. We developed a novel model for predicting lymph node metastasis...

    Authors: Xingdan Guo, Chunhua Lin, Jing Zhao and Mi Tang
    Citation: BMC Cancer 2022 22:1333
    Content type: Research Published on:

  22. Ipilimumab is a fully human monoclonal antibody directed against cytotoxic T-lymphocyte antigen-4 , a key negative regulator of T-cell activation approved by the Food and Drug Administration as of March 2011 f...

    Authors: Olga Venditti, Delia De Lisi, Marco Caricato, Damiano Caputo, Gabriella Teresa Capolupo, Chiara Taffon, Elisa Pagliara, Sofia Battisi, Anna Maria Frezza, Andrea Onetti Muda, Giuseppe Tonini and Daniele Santini
    Citation: BMC Cancer 2015 15:87
    Content type: Case report Published on:

  23. Median overall survival (OS) of patients with melanoma brain metastases (MBM) is usually 6 months or less. There are rare reports of patients with treated MBM who survived for years. These outlier cases repres...

    Authors: Sarah Weiss, Farbod Darvishian, Jyothi Tadepalli, Richard Shapiro, John Golfinos, Anna Pavlick, David Polsky, Tomas Kirchhoff and Iman Osman
    Citation: BMC Cancer 2015 15:926
    Content type: Case report Published on:

  24. Conventional-transarterial chemoembolization (C-TACE) was proven to improve overall survival (OS) in hepatocellular carcinoma (HCC) patients with portal vein tumor thrombus (PVTT), drug-eluting microsphere-TAC...

    Authors: Junwei Chen, Lisha Lai, Junyang Luo, Haofan Wang, Mingan Li and Mingsheng Huang
    Citation: BMC Cancer 2022 22:1242
    Content type: Research Published on:

  25. Postoperative central diabetes insipidus (CDI) is commonly observed in craniopharyngioma (CP) patients, and the inflammatory response plays an important role in CPs. We aimed to evaluate the predictive value o...

    Authors: Jing Wang, Guanghui Wang, Lidong Cheng, Hongtao Zhu, Junwen Wang, Xinmin Ding, Hongquan Niu, Kai Zhao and Kai Shu
    Citation: BMC Cancer 2024 24:572
    Content type: Research Published on:

  27. Nephrectomy, whether in the era of cytokine therapy or targeted therapy, has an important role in the treatment of metastatic renal cell carcinoma. With the advent of immunotherapy, immunotherapy combined with...

    Authors: Hanzhi Dong, Yuan Cao, Yan Jian, Jun Lei, Weimin Zhou, Xiaoling Yu, Xiquan Zhang, Zhiqiang Peng and Zhe Sun
    Citation: BMC Cancer 2023 23:943
    Content type: Research Published on:

  29. Rituximab has been confirmed to improve the survival of patients with B cell indolent non-Hodgkin lymphomas (B-iNHLs) in Western world as previously reported, however, it is rarely reported in Chinese cohort. ...

    Authors: Zengjun Li, Fei Li, Shuhua Yi, Zhimin Gu, Zhen Yu, Yan Xu, Xiaoyan Feng, Wei Liu, Dehui Zou, Junyuan Qi, Fenghuang Zhan and Lugui Qiu
    Citation: BMC Cancer 2015 15:555
    Content type: Research article Published on:

  30. Hepatocellular carcinoma (HCC) is the sixth most common cancer and the second leading cause of cancer-related deaths worldwide. Despite new technologies in diagnosis and treatment, the incidence and mortality ...

    Authors: Hongying Liu, Xieqi Wang, Bing Feng, Lipeng Tang, Weiping Li, Xirun Zheng, Ying Liu, Yan Peng, Guangjuan Zheng and Qinglian He
    Citation: BMC Cancer 2018 18:661
    Content type: Research article Published on:

  31. Advances in multiple myeloma treatment and a proliferation of treatment options have resulted in improved survival rates and periods of symptom-free remission for many multiple myeloma patients. As a result, h...

    Authors: Carrie Dombeck, Teresa Swezey, Juan Marcos Gonzalez Sepulveda, Bryce B. Reeve, Thomas W. LeBlanc, David Chandler and Amy Corneli
    Citation: BMC Cancer 2023 23:65
    Content type: Research Published on:

  32. To compare the effects of resistance training versus passive physical therapy on bone turnover markers (BTM) in the metastatic bone during radiation therapy (RT) in patients with spinal bone metastases. Second...

    Authors: Harald Rief, Georg Omlor, Michael Akbar, Thomas Bruckner, Stefan Rieken, Robert Förster, Ingmar Schlampp, Thomas Welzel, Tilman Bostel, Heinz Jürgen Roth and Jürgen Debus
    Citation: BMC Cancer 2016 16:231
    Content type: Research article Published on:

  33. Real-world data (RWD) is increasingly being embraced as an invaluable source of information to address clinical and policy-relevant questions that are unlikely to ever be answered by clinical trials. However, ...

    Authors: Lucy Gately, Katharine Drummond, Mark Rosenthal, Rosemary Harrup, Anthony Dowling, Andrew Gogos, Zarnie Lwin, Ian Collins, David Campbell, Elizabeth Ahern, Claire Phillips, Hui K. Gan, Iwan Bennett, Oliver M. Sieber and Peter Gibbs
    Citation: BMC Cancer 2022 22:604
    Content type: Research Published on:

  35. Tumor lymphangiogenesis plays an important role in promoting growth and metastasis of tumors, but no antilymphangiogenic agent is used clinically. Based on the effect of norcantharidin (NCTD) on lymphangiogene...

    Authors: Xin-Ping Li, Wei Jing, Jian-Jun Sun, Zhong-Yan Liu, Jing-Tao Zhang, Wei Sun, Wei Zhu and Yue-Zu Fan
    Citation: BMC Cancer 2015 15:527
    Content type: Research article Published on:

  36. Chronic Lymphocytic Leukemia (CLL) is the most frequent lymphoproliferative disorder in western countries and is characterized by a remarkable clinical heterogeneity. During the last decade, multiple genomic s...

    Authors: Adrián Mosquera Orgueira, Beatriz Antelo Rodríguez, Natalia Alonso Vence, José Ángel Díaz Arias, Nicolás Díaz Varela, Manuel Mateo Pérez Encinas, Catarina Allegue Toscano, Elena María Goiricelaya Seco, Ángel Carracedo Álvarez and José Luis Bello López
    Citation: BMC Cancer 2019 19:515
    Content type: Research article Published on:

  37. The prognosis of hepatocellular carcinoma with portal vein tumor thrombus remains extremely poor. This pilot study aimed to evaluate the technical feasibility, effectiveness and safety of transcatheter chemoem...

    Authors: Biao Yang, Chun-Lin Li, Wen-hao Guo, Tian-qiang Qin, He Jiao, Ze-jun Fei, Xuan Zhou, Lin-jia Duan and Zheng-yin Liao
    Citation: BMC Cancer 2018 18:101
    Content type: Research article Published on:

  39. The alternatively spliced V region or type III connecting segment III (IIICS) of fibronectin is important in early development, wound healing, and tumorigenesis, however, its role in oral cancer has not been f...

    Authors: Pachiyappan Kamarajan, Angeles Garcia-Pardo, Nisha J D'Silva and Yvonne L Kapila
    Citation: BMC Cancer 2010 10:330
    Content type: Research article Published on:

  40. WNT/βcatenin (WNTβ) pathway is activated in early stages of embryonic development. We aimed to evaluate the significance of βcatenin in germ cell tumors (GCTs) and explore associations with the inflamed enviro...

    Authors: Michal Chovanec, Zuzana Cierna, Viera Miskovska, Katarina Machalekova, Katarina Kalavska, Katarina Rejlekova, Daniela Svetlovska, Dusan Macak, Stanislav Spanik, Karol Kajo, Pavel Babal, Michal Mego and Jozef Mardiak
    Citation: BMC Cancer 2018 18:1062
    Content type: Research article Published on:

  41. DNA damage response has been clearly described as an anti-cancer barrier in early human tumorigenesis. Moreover, interestingly, testicular germ cell tumors (TGCTs) have been reported to lack the DNA Damage Res...

    Authors: Stefania Staibano, Gennaro Ilardi, Vincenza Leone, Chiara Luise, Francesco Merolla, Francesco Esposito, Francesco Morra, Maria Siano, Renato Franco, Alfredo Fusco, Paolo Chieffi and Angela Celetti
    Citation: BMC Cancer 2013 13:433
    Content type: Research article Published on:

    The Retraction Note to this article has been published in BMC Cancer 2021 21:100

  42. Osteosarcoma is the most prevalent primary bone malignancy in children and young adults. These tumors are highly metastatic, leading to poor outcome. We previously demonstrated that Cysteine-rich protein 61 (C...

    Authors: Nadia Habel, Bojana Stefanovska, Dimitri Carène, Ana Patiño-Garcia, Fernando Lecanda and Olivia Fromigué
    Citation: BMC Cancer 2019 19:62
    Content type: Research article Published on:

  43. Plasma cell disorders are a rare group of hematological malignancies that accounts for 10% of all hematological neoplasms. Solitary plasmacytomas are rarer entities accounting for less than 5% of all the plasm...

    Authors: Sridevi Hanaganahalli Basavaiah, Flora D. Lobo, Cheryl Sarah Philipose, Pooja K. Suresh, Saraswathy Sreeram, Hema Kini, Kausalya K. Sahu and Krishna Prasad
    Citation: BMC Cancer 2019 19:801
    Content type: Research article Published on:

  44. Cancer therapies that kill cancer cells without affecting normal cells is the ultimate mode of treating cancers. The VP3, an avian virus-derived protein, can specifically initiate cell death through several si...

    Authors: Ruzila Ismail, Zeenathul Nazariah Allaudin, Rasedee Abdullah, Mohd-Azmi Mohd Lila, Nik-Mohd-Afizan Nik Abd. Rahman and Sheikh-Omar Abdul Rahman
    Citation: BMC Cancer 2016 16:461
    Content type: Research article Published on:

  45. FAM3B/PANDER is a novel cytokine-like protein that induces apoptosis in insulin-secreting beta-cells. Since in silico data revealed that FAM3B can be expressed in prostate tumors, we evaluated the putative rol...

    Authors: Paula Maciel-Silva, Izabela Caldeira, Icaro de Assis Santos, Ana Claudia Oliveira Carreira, Flavia Ramos Siqueira, Eliane Antonioli, Anna Carla Goldberg, José Ernesto Belizário and Humberto Miguel Garay-Malpartida
    Citation: BMC Cancer 2018 18:90
    Content type: Research article Published on:

  46. Radiofrequency ablation (RFA) can not only effectively kill hepatocellular carcinoma (HCC) tumour cells but also release tumour antigens that can provoke an immune response. However, there is no consensus rega...

    Authors: Shunli Shen, Hong Peng, Ye Wang, Ming Xu, Manxia Lin, Xiaoyan Xie, Baogang Peng and Ming Kuang
    Citation: BMC Cancer 2018 18:117
    Content type: Research article Published on:

  47. Circulating tumor cell (CTC)-filtration methods capture high numbers of CTCs in non-small-cell lung cancer (NSCLC) and metastatic prostate cancer (mPCa) patients, and hold promise as a non-invasive technique f...

    Authors: Emma Pailler, Marianne Oulhen, Fanny Billiot, Alexandre Galland, Nathalie Auger, Vincent Faugeroux, Corinne Laplace-Builhé, Benjamin Besse, Yohann Loriot, Maud Ngo-Camus, Merouan Hemanda, Colin R. Lindsay, Jean-Charles Soria, Philippe Vielh and Françoise Farace
    Citation: BMC Cancer 2016 16:477
    Content type: Technical advance Published on:

  48. Gliomas are the most common primary intracranial tumor worldwide. The maintenance of telomeres serves as an important biomarker of some subtypes of glioma. In order to investigate the biological role of RTEL1 ...

    Authors: Guanjie Wang, Xiaojuan Ren, Jianying Li, Rongrong Cui, Xumin Zhao, Fang Sui, Juan Liu, Pu Chen, Qi Yang, Meiju Ji, Peng Hou, Ke Gao and Yiping Qu
    Citation: BMC Cancer 2024 24:385
    Content type: Research Published on:

  49. Epithelial-mesenchymal transition (EMT) played an important role in the progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). However, whether sorafenib could be used ...

    Authors: Shuying Dong, Jian Kong, Fandong Kong, Jinge Kong, Jun Gao, Liang Ji, Bing Pan, Lian Chen, Lemin Zheng and Wenbing Sun
    Citation: BMC Cancer 2015 15:939
    Content type: Research article Published on:

  50. The use of flaps in vulvar cancer-related reconstruction has been increasing, but few studies have evaluated the outcome and quality of life of patients after this surgery. The purpose of this study was to eva...

    Authors: Wei Zhang, Ang Zeng, Jiaxin Yang, Dongyan Cao, Xiaodong He, Xiaojun Wang, Yan You, Jie Chen, Jinghe Lang and Keng Shen
    Citation: BMC Cancer 2015 15:851
    Content type: Research article Published on:

Featured videos

View featured videos from across the BMC-series journals

Submit manuscript

Follow

BMC Cancer

ISSN: 1471-2407

Contact us